PGHL5,435.00

Procter & Gamble Health Limited

· Pharma & Health
₹ CrorePeersSANOFICONRSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹9,022 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
30/06/2024
FY26
30/06/2025
FY27
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation48.1
+ Finance Costs0.7
+ Interest Income11.7
+ Share-based Payments0.7
+ Unrealised FX (Gain) / Loss2.0
+ Other Non-cash Items-7.8
+ Other — Cash Effects are Investing / Financing-2.1
Changes in Working Capital
+ Inventories23.1
+ Trade Receivables — Current29.2
+ Other Financial Assets — Current18.3
+ Trade Payables — Current-71.6
+ Other Current Liabilities-11.1
+ Provisions — Current-1.1
Cash from Operating Activities
Profit Before Tax (per I/S)273.388.8129.1
+ Total Adjustments (incl. Working Capital)40.2
Cash from Operations (pre-tax)313.5
+ Income Taxes Paid85.2
Cash from Operating Activities228.3
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)21.7
+ Disp of Fixed Assets0.1
+ Interest Received — Investing12.6
+ Other Inflows / (Outflows) — Investing2.1
Cash from Investing Activities-6.9
Cash from Financing Activities
+ Payment of Lease Liabilities3.1
+ Dividends Paid415.0
Cash from Financing Activities-418.1
Net Changes in Cash (pre-FX)-196.7
Net Changes in Cash-196.7
Closing Cash238.7
Reference Items
EBITDA306.090.399.6
EBITDA Margin %26.5826.6727.38
Free Cash Flow (CFO − Capex)206.6
Free Cash Flow per Basic Share124.43
Cash Flow to Net Income1.14
Cash Paid for Taxes85.2
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.